Epidemiology and risk factors for mortality among methicillin-resistant Staphylococcus aureus bacteremic patients in Southern Brazil
暂无分享,去创建一个
M. Ramirez | D. Falci | C. Dias | R. Cassol | C. V. Riche
[1] M. Loeb,et al. Staphylococcus aureus bacteremia mortality: A systematic review and meta-analysis. , 2022, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[2] M. Charlson,et al. Charlson Comorbidity Index: A Critical Review of Clinimetric Properties , 2022, Psychotherapy and Psychosomatics.
[3] C. Sprung,et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 , 2021, Intensive Care Medicine.
[4] L. C. Romero,et al. Insights into the epidemiology of community-associated methicillin-resistant Staphylococcus aureus in special populations and at the community-healthcare interface , 2021, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[5] M. Holmes,et al. Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey. , 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[6] P. Bispo,et al. Community-genotype methicillin-resistant Staphylococcus aureus skin and soft tissue infections in Latin America: a systematic review , 2021, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[7] P. d’Azevedo,et al. Resistance profile to antimicrobials agents in methicillin-resistant Staphylococcus aureus isolated from hospitals in South Brazil between 2014-2019 , 2020, Revista da Sociedade Brasileira de Medicina Tropical.
[8] F. Zervou,et al. Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] L. Baddour,et al. Resilience of the Pitt Bacteremia Score: Three Decades and Counting. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] W. Kern,et al. Burden of bacterial bloodstream infection - A brief update on epidemiology and significance of multidrug-resistant pathogens. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[11] L. Baddour,et al. Resilience of the Pitt Bacteremia Score: 3 Decades and Counting. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] Robin Patel,et al. Lack of correlation of virulence gene profiles of Staphylococcus aureus bacteremia isolates with mortality. , 2019, Microbial pathogenesis.
[13] Ronald N. Jones,et al. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program , 2019, Antimicrobial Agents and Chemotherapy.
[14] J. Thaden,et al. Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] Rosemary C. She,et al. Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] S. Monecke,et al. A novel multidrug-resistant PVL-negative CC1-MRSA-IV clone emerging in Ireland and Germany likely originated in South-Eastern Europe. , 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[17] M. Hellmich,et al. Survival following Staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care. , 2018, The Journal of infection.
[18] Sahreena S. Lakhundi,et al. Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology , 2018, Clinical Microbiology Reviews.
[19] J. Shu,et al. Risk factors of treatment failure and 30-day mortality in patients with bacteremia due to MRSA with reduced vancomycin susceptibility , 2018, Scientific Reports.
[20] O. Weiland,et al. Staphylococcus aureus bacteraemia and endocarditis – epidemiology and outcome: a review , 2018, Infectious diseases.
[21] P. Linden,et al. Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment , 2017, Critical Care.
[22] M. Dowzicky,et al. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial , 2017, Annals of Clinical Microbiology and Antimicrobials.
[23] Samuel M Brown,et al. Physician Variation in Time to Antimicrobial Treatment for Septic Patients Presenting to the Emergency Department , 2017, Critical care medicine.
[24] D. Falci,et al. Absence of Correlation Between Vancomycin Consumption and Minimum Inhibitory Concentration of Methicillin-Resistant Staphylococcus aureus Isolates , 2017, Infection Control & Hospital Epidemiology.
[25] Vance G. Fowler,et al. Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management , 2015, Clinical Microbiology Reviews.
[26] A. Costa-Pereira,et al. Classification of healthcare-associated infection: a systematic review 10 years after the first proposal , 2014, BMC Medicine.
[27] S. V. van Hal,et al. Predictors of Mortality in Staphylococcus aureus Bacteremia , 2012, Clinical Microbiology Reviews.
[28] A. Marra,et al. Nosocomial Bloodstream Infections in Brazilian Hospitals: Analysis of 2,563 Cases from a Prospective Nationwide Surveillance Study , 2011, Journal of Clinical Microbiology.
[29] Daniel J Sexton,et al. Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.
[30] C. Arias,et al. Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study , 2018, The Journal of antimicrobial chemotherapy.